je.st
news
Tag: results
Trade agreements: Existing US pacts deliver mixed results
2015-09-03 15:07:00| Daily apparel & textile news and comment - from just-style.com
While much political attention in the United States has been focused on the merits of sweeping proposed free-trade agreements (FTAs) such as the Trans-Pacific Partnership (TPP) and the Transatlantic Trade & Investment Partnership (TTIP) with the European Union (EU), US textile and apparel executives report mixed results from deals already in place.
Tags: results
existing
trade
mixed
Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI
2015-09-03 07:58:28| Biotech - Topix.net
Allergan plc. today announced positive topline results from RECAPTURE 1 and 2, the pivotal Phase III studies evaluating the antibiotic AVYCAZ as a treatment for adult hospitalized patients with complicated urinary tract infections , including pyelonephritis.
School Specialty's (SCHS) CEO Joseph Yorio on Q1 2016 Results - Earnings Call Transcript
2015-09-03 01:33:27| Furniture - Topix.net
Good day, ladies and gentlemen, and welcome to School Specialty's short year 2015 first quarter conference call. At this time, I would like to turn the call over to today's host, Glenn Wiener.
Tags: results
call
school
joseph
IPC releases PCB Industry Results for July 2015.
2015-09-02 14:31:06| Industrial Newsroom - All News for Today
According to IPC's monthly North American Printed Circuit Board Statistical Program, year-over-year sales and order growth continued in July and book-to-bill ratio strengthened to 1.09. Total shipments increased 2.7% in July 2015 from July 2014. Year-to-date shipment growth remained at -0.3, reflecting negative growth rates seen earlier this year. Compared to previous month, PCB shipments were down 14.3%. PCB bookings grew 5.8% compared to July 2014, increasing year-to-date order growth to 3.9%.
Tags: results
july
industry
releases
Janssen, Bayer HealthCare announce results from landmark studies...
2015-09-02 08:58:45| Chemicals - Topix.net
Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS and XANTUS , their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation . The results found the rates and patterns of major bleeding in routine clinical practice were low and generally consistent with those observed in Phase 3 clinical research.
Tags: results
studies
healthcare
announce
Sites : [466] [467] [468] [469] [470] [471] [472] [473] [474] [475] [476] [477] [478] [479] [480] [481] [482] [483] [484] [485] next »